Skip to search boxSkip to navigationSkip to main content

Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death

  • Xuejia Kang
    ,
  • Yuxin Cai
    ,
  • Qi Wang
    ,
  • Chuanyu Wang
    ,
  • Wu Chen
    ,
  • Wen Yang
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Disulfiram copper complex [Cu(DDC)2] nanoparticles have been explored as promising anticancer agents but with concerns of toxic side effects. To improve tumor specificity and enhance anticancer efficacy, we developed a novel [copper sulfide nanoparticle (CuS NP) + disulfiram prodrug (DQ) micelle + near-infrared (NIR) laser] (CDL) combination therapy. DQ, a reactive oxygen species (ROS)-responsive prodrug, can be selectively activated at the tumor site with elevated ROS to release DDC and form Cu(DDC)2 in situ. The CuS NP + NIR laser treatment can effectively increase the intra-tumor ROS levels and efficiently activate the DQ prodrug. The CDL therapy kills cancer cells through multiple mechanisms, including ROS amplification cascade and Cu(DDC)2 chemotherapy. NIR light-triggered tumor-specific “nontoxic-to-toxic” transition can significantly improve the specificity of anticancer effects and reduce systemic toxicity. Also, CDL therapy can effectively induce immunogenic cell death (ICD) and has the potential of eliciting antitumor immunity.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

120972

Journal (Volume, Issue Number)

International Journal of Pharmaceutics (Volume 607)

Publication milestones

  • Published - 09/25/2021

Publication status

Published - 09/25/2021

ISSN

0378-5173

Publication IDs

  • Scopus: 85113205208
  • PubMed: 34363916

Publication metrics

Metrics

Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
33
Social media
7
Citation count
32

Funding Details

This work was financially supported by the following resources: Launch Innovation Award (F, Li), Auburn University start-up fund (F. Li), NIH MIRA R35GM133795 (P. Chen). We thank Dr. Melissa Boersma at Auburn University Mass Spectrometry Center for LC/MS analysis. This work was financially supported by the following resources: Launch Innovation Award (F, Li), Auburn University start-up fund (F. Li), NIH MIRA R35GM133795 (P. Chen). We thank Dr. Melissa Boersma at Auburn University Mass Spectrometry Center for LC/MS analysis.
FundersFunding number
Auburn University Mass Spectrometry Center
-
NIH
-
NIGMS
R35GM133795
AU
-